Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 16, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 9, 2001
- OTC News in Brief
April 9, 2001
- REGULATORY NEWS IN BRIEF -2-
April 9, 2001
- Aiming at Top 5 between 2005 and 2010: Mr Dunoyer of GSK
April 9, 2001
- REGULATORY NEWS IN BRIEF -1-
April 9, 2001
- Shimadzu, Eisai Codevelop Washing Validation Support System
April 9, 2001
- Sysmex Opens Technical Service Center in Africa
April 9, 2001
- Lysosome Disease Added as Designated Disease
April 9, 2001
- Yamanouchi Wants to Make Lipitor No. 1 Statin in Japan
April 9, 2001
- Nihon Schering: New in vitro Diagnostic for Rapid PSA Detection
April 9, 2001
- Public Is Not Fully Aware of Life-Style-Related Diseases: Korosho Survey
April 9, 2001
- Sysmex, IRC Strengthen Cooperative Relationship
April 9, 2001
- Korosho to Announce Name of Generics Approved Soon after Approval
April 9, 2001
- Medical Divece News in Brief
April 9, 2001
- Rush to Change Approvals for Products Containing Cattle-Derived Materials
April 9, 2001
- JIRA to Propose Introduction of Medical Devices Law
April 9, 2001
- Bringing ICH Agreement to Asia: 3rd IFPMA Asian Regulatory Conference
April 9, 2001
- NEC Develops Home Health Management System Using Internet
April 9, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
April 9, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…